Suppr超能文献

环磷酸腺苷(cAMP)依赖性蛋白激酶催化亚基与蛋白激酶抑制剂之间相互作用中疏水残基重要性的证据。

Evidence for the importance of hydrophobic residues in the interactions between the cAMP-dependent protein kinase catalytic subunit and the protein kinase inhibitors.

作者信息

Baude E J, Dignam S S, Reimann E M, Uhler M D

机构信息

Department of Biological Chemistry, University of Michigan, Ann Arbor 48109.

出版信息

J Biol Chem. 1994 Jul 8;269(27):18128-33.

PMID:8027074
Abstract

The protein kinase inhibitors (PKIs) are potent inhibitors of the catalytic (C) subunit of cAMP-dependent protein kinase. In this study, the interaction between Phe10 of PKI and the C subunit residues Tyr235 and Phe239 was investigated using site-directed mutagenesis. Previous peptide studies as well as the crystal structure suggested that these residues may play a key role in C-PKI binding. The C subunit codons for Tyr235 and Phe239 were changed singly and in combination to serine codons. The mutated C alpha proteins were overexpressed in Escherichia coli. The purified C alpha Y235S, C alpha F239S, and C alpha Y235S/F239S proteins did not exhibit any differences in their Km(app) for the peptide substrate Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) or Vmax(app), with respect to wild-type C alpha. All of the C subunit mutants displayed less than 2-fold changes in their Km(app) for ATP. The PKI alpha isoform displayed increased IC50 values for C alpha Y235S (71-fold), C alpha F239S (150-fold), and C alpha Y235S/F239S (1800-fold). Similarly, the PKI beta 1 protein showed increased IC50 values against the C alpha Y235S, C alpha F239S, and C alpha Y235S/F239S proteins, 9.4-, 11-, and 44-fold, respectively. In addition, the PKI alpha F10 codon was altered to an alanine codon, and this mutation decreased its ability to inhibit C alpha kinase activity, but did not affect its ability to inhibit C alpha Y235S/F239S. The mutation of Tyr235 and Phe239 to serines, however, did not alter the ability of the type II R subunit to inhibit phosphotransferase activity. These results suggest that C alpha Y235 and C alpha F239 are important for specific inhibition by both PKI alpha and PKI beta but not the type II R subunit and that mutations at these residues would be useful for in vivo analysis of C-PKI interactions.

摘要

蛋白激酶抑制剂(PKIs)是环磷酸腺苷(cAMP)依赖性蛋白激酶催化(C)亚基的强效抑制剂。在本研究中,利用定点诱变研究了PKI的苯丙氨酸10(Phe10)与C亚基残基酪氨酸235(Tyr235)和苯丙氨酸239(Phe239)之间的相互作用。先前的肽研究以及晶体结构表明,这些残基可能在C-PKI结合中起关键作用。将Tyr235和Phe239的C亚基密码子分别或组合改变为丝氨酸密码子。突变的Cα蛋白在大肠杆菌中过表达。纯化的CαY235S、CαF239S和CαY235S/F239S蛋白在肽底物肯普肽(Leu-Arg-Arg-Ala-Ser-Leu-Gly)的表观米氏常数(Km(app))或最大反应速度(Vmax(app))方面,与野生型Cα相比没有任何差异。所有C亚基突变体对ATP的表观米氏常数(Km(app))变化均小于2倍。PKIα同工型对CαY235S(71倍)、CαF239S(150倍)和CαY235S/F239S(1800倍)的半数抑制浓度(IC50)值增加。同样,PKIβ1蛋白对CαY235S、CαF239S和CαY235S/F239S蛋白的半数抑制浓度(IC50)值分别增加了9.4倍、11倍和44倍。此外,将PKIα的F10密码子改变为丙氨酸密码子,该突变降低了其抑制Cα激酶活性的能力,但不影响其抑制CαY235S/F239S的能力。然而,将Tyr235和Phe239突变为丝氨酸并没有改变II型R亚基抑制磷酸转移酶活性的能力。这些结果表明,CαY235和CαF239对于PKIα和PKIβ的特异性抑制很重要,但对于II型R亚基则不然,并且这些残基处的突变将有助于C-PKI相互作用的体内分析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验